Indications
Treatment of essential hypertension. Imprida is indicated in patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.
Composition
- Active substance
- valsartan, amlodipine (as amlodipine besilate)
- International name (INN)
- amlodipine;valsartan
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Imprida
- Active substance
- valsartan, amlodipine (as amlodipine besilate)
- ATC code
- C09DB01
- Therapeutic area
- Hypertension
- Marketing authorisation holder
- Novartis Europharm Ltd